4//SEC Filing
Mordwinkin Nicholas Michael 4
Accession 0001209191-22-043897
CIK 0001645666other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:47 PM ET
Size
5.5 KB
Accession
0001209191-22-043897
Insider Transaction Report
Form 4
Mordwinkin Nicholas Michael
Chief Business Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-08-01+200,000→ 200,000 totalExercise: $9.35Exp: 2032-07-31→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]Twenty five percent (25%) of the shares will vest on July 11, 2023, and 1/48th of the total shares will vest each month thereafter, subject to Reporting Person continuing to provide service through such date.
Documents
Issuer
Kezar Life Sciences, Inc.
CIK 0001645666
Entity typeother
Related Parties
1- filerCIK 0001937229
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 4:47 PM ET
- Size
- 5.5 KB